The Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU) has announced today the decision of the Jury of the VI Edition of its Awards, made up of thirteen professionals of recognized prestige in the field of rare diseases.

With these awards, AELMHU recognizes the contribution of institutions, patient associations and health professionals in the field of rare pathologies, in order to continue recognizing year after year the most relevant contributions both in the visibility and awareness of these pathologies and in their research and treatments.

Access the full press release here.